# Vivos Therapeutics, Inc. (VVOS)

**Exchange:** NASDAQ  
**Market cap:** $7M  
**Price:** $0.64 (-8.73%)

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $17M | $11M | -$20M | -$21M | — |
| 2024 | $15M | $9M | -$11M | -$11M | — |
| 2023 | $14M | $8M | -$17M | -$14M | — |
| 2022 | $16M | $10M | -$25M | -$24M | — |
| 2021 | $17M | $13M | -$20M | -$20M | — |
| 2020 | $13M | $10M | -$12M | -$12M | — |
| 2019 | $11M | $9M | -$11M | -$11M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $25M | $27M | -$1M | $2M | $753,000 |
| 2024 | $15M | $7M | $8M | $6M | — |
| 2023 | $11M | $10M | $411,000 | $2M | — |
| 2022 | $14M | $9M | $5M | $4M | — |
| 2021 | $34M | $8M | $26M | $24M | $1M |
| 2020 | $25M | $8M | $17M | $18M | $1M |
| 2019 | $8M | $9M | -$3M | $469,353 | $4M |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | -$15M | $2M | -$18M |
| 2024 | -$13M | $568,000 | -$13M |
| 2023 | -$12M | $803,000 | -$13M |
| 2022 | -$20M | $924,000 | -$21M |
| 2021 | -$16M | $2M | -$18M |
| 2020 | -$6M | $120,000 | -$6M |
| 2019 | -$5M | $175,599 | -$6M |

Source: [CompaniesByCap](https://companiesbycap.com/company/VVOS)